Page last updated: 2024-09-03

geraniin and warfarin

geraniin has been researched along with warfarin in 3 studies

Compound Research Comparison

Studies
(geraniin)
Trials
(geraniin)
Recent Studies (post-2010)
(geraniin)
Studies
(warfarin)
Trials
(warfarin)
Recent Studies (post-2010) (warfarin)
9416636,5732,14314,728

Protein Interaction Comparison

ProteinTaxonomygeraniin (IC50)warfarin (IC50)
Vitamin K epoxide reductase complex subunit 1 Homo sapiens (human)0.0088

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Ito, H1
Hatano, T; Ishimoto, H; Ito, H; Myojin, Y; Shibata, M; Sugimoto, Y; Tai, A1
Ahemad, N; Goh, BH; Khan, SU; Looi, D; Palanisamy, UD1

Reviews

1 review(s) available for geraniin and warfarin

ArticleYear
Metabolites of the ellagitannin geraniin and their antioxidant activities.
    Planta medica, 2011, Volume: 77, Issue:11

    Topics: Animals; Antioxidants; Biphenyl Compounds; Chromatography, High Pressure Liquid; Coumarins; Free Radical Scavengers; Geranium; Glucosides; Hydrolyzable Tannins; Intestinal Mucosa; Intestines; Magnetic Resonance Spectroscopy; Metabolic Networks and Pathways; Picrates; Pyrones; Rats

2011

Other Studies

2 other study(ies) available for geraniin and warfarin

ArticleYear
In vivo anti-inflammatory and antioxidant properties of ellagitannin metabolite urolithin A.
    Bioorganic & medicinal chemistry letters, 2011, Oct-01, Volume: 21, Issue:19

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Coumarins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Discovery; Drug Evaluation, Preclinical; Edema; Free Radical Scavengers; Glucosides; Glucuronides; Humans; Hydrolyzable Tannins; Lythraceae; Mice; Mice, Inbred ICR; Rats

2011
Metabolites of the ellagitannin, geraniin inhibit human ACE;
    International journal of food sciences and nutrition, 2021, Volume: 72, Issue:4

    Topics: Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Carboxypeptidases; Computer Simulation; Coumarins; Ellagic Acid; Glucosides; Humans; Hydrolyzable Tannins; Hypertension; Molecular Docking Simulation; Peptidyl-Dipeptidase A; Polyphenols; Rabbits

2021